Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active surveillance versus intravesical bacillus Calmette-Guérin for high-grade T1 bladder cancer with negative second transurethral resection: the randomized noninferiority phase 3 JCOG1019 trial. Eur Urol. 2026;89:437–445

IF 29.1 1区医学 Q1 UROLOGY & NEPHROLOGY

European urology Pub Date : 2026-09-01 Epub Date: 2026-04-22 DOI:10.1016/j.eururo.2026.03.032

Niyati Lobo, Roberto Contieri, Laura Mertens, Ashish M. Kamat

引用次数: 0

Re: Kitamura H, Tsukamoto T, Kakehi Y，等。主动监测与膀胱内卡介苗-谷氨酰胺治疗第二次经尿道切除阴性的高级别T1膀胱癌：随机非劣效性3期JCOG1019试验Urol欧元。在出版社。http://dx.doi.org/10.1016/j.eururo.2026.01.008。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology 医学-泌尿学与肾脏学

CiteScore

43.00

自引率

2.60%

发文量

1753

审稿时长

23 days

期刊介绍： European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.